Arab Health 2016 Miocare Healthcare Tablet Range and Solutions RDP Healthcare Mobile and Pharma solutions
GCC Pharma Market Review Eastwood Park Aras Group launches new training facility in UAE
Plinth 2000 -Dialysis Chair
Sidhil Investing for the International Market Physicool Cooling Mist Range
Briffa Trademark IP Brand Power in the GCC
www.middleeasthospital.com
Personalized Health Management For InternatIonally-Based ClIents Quality Health Management (QHM) has been guiding the global needs of clients, payers, providers and patients with PPO, administrative and specialty services for over ten years. We make a world of difference to the bottom line of international companies who seek cost reduction and efficient management services.
QHM services: n Extensive network of providers in the United States and over 80 countries n Efficient claims service and custom claims repricing n Experienced medical case management n Superior account management and 24 hour member service n Specialty care services — Solid organ/bone marrow transplantation — Oncology risk management — Pharmacy benefits
rd wa nA
MEH 20 1
th and Innova tio
Official Nominee for 2015 Awards
Q uali t y H e alt H M anag e M e n t Miami Lakes, Florida,USA (305) 821-8430 | Toll Free: (877) 688-8821 For more information, contact Mike Tanousis Email: mtanousis@me.com www.qhmanagement.com
Middle East Hospital magazine
Editorial Editor’s Introduction
January/February 2016 Contents Eastood Park launch a new training facility in the UAE
Welcome to the January/February issue of MEH. This issue previews Arab Health 2016, the largest and most important health trade fair in the region, and feature some of the companies and new products that will be on show.
Product Focus: RDP launches new range in GCC
Eastwood Park the training facility are opening a new training facility in the UAE Kimal will be showcasing their range of Altius Central Venous Catheters; RDP Healthcare will be launching their new range plus welook at the Mio Healthcare tablet range and Plinth 200, Physicool are launching a new cooling mist range Adam,Rouilly, bed manufaturers Sidhil are also profiled.
Arab Health 2016 Preview: 25-28 January 2016 at the Dubai International Con vention and Exhibition Centre.
Product Focus: Physicool launch new Cooling Mist Range
pg 28-29
Company profile: Sidhil - Investing for the International Market
pg 30-31
Miocare Healthcare Tablet Range nominated for MEH Health Innovation Award
pg 32-34
Specialist article: Informed consent in clincial research by Ahmad Zaher AL Samarah MD, Clin Group Holding
pg 36-38
Abu Dhabi Health Review
pg. 40-43
Special feature: The Brand Power by PraveenPlllai
Malem Medical
We have an excellent selection of specialist articles on a range of topics
Enjoy this issue and have a successful Arab Health 2016. Mike Tanousis - Publisher Tel: 0044 1702 296776 Mobile: 0044 0776 1202468 miketanousis@middleeasthospital.com Skype: mike.tanousis1 Guy Rowland - Editor Mob: 0044 7909 088369 guyrowland@middleeasthospital.com Skype: guyrowland Twitter: @MEH_editor Chris Silk - Associate Publisher chrissilk@middleeasthospital.com
Ken Findlay - Media Editor ken@perceptionsmgt.co.uk Regional Director Abdullah Al Thari Armada Network – Healthcare Services Olaya, Mosa Bin Nosair Road Riyadh. Saudi Arabia Tel : +966 595 99 22 11 althari@gmail.com
Shoeburyness Essex. SS3 9EZ United Kingdom If you would like to discuss advertising or contributing editorial to Middle East Hospital please contact the Publisher or Editor, or email editorial@middleeasthospital.com
MEH Publishing & Trading Group 151 Church Rd Shoeburyness SS3 9EZ
www.middleeasthospital.com
January/February 2016 | 3
Middle East Hospital magazine
Aras Eastwood Park Training - delivers new Dubai training facility
New partnership announced – Aras Eastwood Park Training - delivers new Dubai training facility Eastwood Park is delighted to announce a partnership with Dubai-based Aras Medical Devices & Equipments Co LLC, a division of the Aras Group. The business will operate as Aras Eastwood Park Training from the new Dubai training facility delivering specialist medical gas training. Aras Eastwood Park reflects a collaboration that has developed over several years; combining the skills and knowledge of two world leading experts, both well-established and highly regarded within medical equipment, education and training. John Thatcher, Eastwood Park’s, CEO emphasised the significance and potential for growth: “Working in partnership with Aras Group enables both organisations to ensure effective accredited medical gas training is more accessible to a much wider audience than before. With access to accredited training, coupled with learning on a simulated medical gas pipeline, will enhance the quality of support and learning for engineers who are able to access Dubai more easily than the UK.” KC Babu, CEO Aras added: “The breadth of our business throughout the Middle East, India, Pakistan and African countries, and further afield, will enable us to work with many organisations who wish to improve their skills in the design, maintenance and safety of medical gas pipelines.” Courses will be delivered by highly experienced medical gas trainers in the new fully equipped medical gas Dubai training centre, where hands on, practical training will allow delegates to learn in a safe, ‘test’ environment. Aras Eastwood Park medical gas courses have been accredited by the internationally respected awarding body, City & Guilds. For training in Dubai, courses can be booked by contacting training@arasgroup.ae or calling (+971) 04 2344457. Further details are available on www.eastwoodparktraining.co.uk and www.arasgroup.ae. Aras Group has been providing healthcare services and industrial engineering solutions across the United Arab Emirates and India for more than four decades, and has been a leading organisation in the field of medical gas pipeline systems and medical equipment for many years. The synergy with Eastwood Park Training is strong, with Eastwood Park delivering not only medical gas training but many other specialist engineering courses and programmes within healthcare internationally for 46 years. www.middleeasthospital.com
January/February 2016 | 4
A special disposable tourniquet to improve your first-try success rate in venous access
• Comfortable strap eases the discomfort of the patient • V section shows accurate alignment to the vein • Vacuum pump amplifies the filling of the vein making it more tense and easier to cannulate • Easy to use patented buckle for single-handed release
Pain saving, time saving and cost saving For more information or to find your nearest distributor, call +33(0)
3 28 55 25 38 or email enquiries@olberon.com
www.olberon.com
KimalA
Middle East Hospital magazine
Market report
Snapshots of the GCC Pharmaceuticals Market
January/February 2013 | 6
www.middleeasthospital.com
KimalAdvert
17/1/13
14:34
Page 1
Middle East Hospital magazine
Market report In recent years, substantial growth in generics manufacturing and a marked shift in disease profile has been witnessed in the GCC. Based on these facts, Frost & Sullivan forecasts that pharmaceutical sales will grow at a compound annual growth rate (CAGR) of 6‐8 percent from 2010‐20; and sales revenues have been pegged between USD 9.9 billion and USD 11.6 billion by 2020.
The GCC Pharmaceuticals Industry
Chart 1: GCC Pharma Sales (CAGR): 2010‐20
Charts 1 and 2 (right) depict pharma sales in the GCC as per CAGR and percentage of GDP, respectively, between 2010 and 2020. Smaller pharma markets such as Qatar and Bahrain are likely to experience higher growth than the comparatively developed market of Saudi Arabia. While Qatar and Bahrain are expected to grow at CAGRs of 11 per cent and 7 per cent, respectively, during 2010‐20, Saudi Arabia is expected to grow at 6 per cent in the same period. Share of Anti‐diabetic and Cardiovascular Drugs set to Rise Anti‐diabetic and cardiovascular drug segments are expected to grow at a fast pace in the near future owing to changing demographics and lifestyles in both emerging and key markets, combined with increasing incidences of cardiovascular diseases in the GCC. While diabetes prevalence in the Middle East and Africa is expected to grow at a CAGR of 3.5 per cent and 3.2 per cent, respectively; muted growth of 1.2 per cent and 2.4 per cent is anticipated in European and Americas regions respectively. Globally, the cardiovascular drugs market
D
Chart 2: Pharmaceuticals Sales as Percentage of GDP: 2010‐20
is expected to have high volatility from 2011‐ 2015 on account of patent expiry. During 2011‐2015, USD 77 billion patented drugs, being currently sold, are expected to expire, including Pfizer’s Lipitor (Lipitor), GlaxoSmithKline’s Avandia (Avandia), and Johnson & Johnson’s Levofloxacin (Levaquin). This may result in the entry of generic unbranded drugs in the GCC and possible rise in drugs volume sales, but decline in revenues. Chart 3 depicts the global incidence of diabetes from 2010‐30.
Chart 3: Increased Prevalence Rate of Diabetes: 2000‐2030
www.middleeasthospital.com
The GCC accounted for approximately 1 per cent of the global pharmaceuticals industry in 2010 and is still at a nascent stage compared to international standards. To compete globally and meet the increasing healthcare demand, the GCC is undergoing a paradigm shift with implementation of reforms, simplification of Government regulations, up gradation and expansion of healthcare infrastructure. The GCC pharmaceuticals market depends primarily on imported drugs and therapeutics. Nearly 80 per cent of total drugs consumed here are imported. This situation provides opportunities to private players to set up their own manufacturing units in the region. The GCC governments are planning to raise their domestic production through investments in the pharmaceutical industry and by adopting liberal trade policies and international healthcare standards. Moreover, the private pharmaceuticals sector in the GCC, which tends to favour branded pharmaceuticals, is marked by tight price controls. GCC Pharma Sector Growth Surpasses Developed Markets The GCC pharmaceuticals sector experienced growth rate of 7 per cent in 2010, whereas developed markets of the US and Europe reported growth of 6 per cent. This has been primarily due to conducive regulatory policies, growing incidence of lifestyle‐related diseases and high drug prices. Growth of the pharmaceuticals sector in developed markets has declined, as several patents have expired recently and generic drugs are increasing. January/February 2016 | 8
W an sl sl
Pa fr fo fir
Middle East Hospital magazine
Market report Saudi Arabia leads pharma sector
the
GCC
In the GCC pharma sector, Saudi Arabia commanded the largest market share of 51 per cent in 2010, followed by the UAE at 33 per cent. Other GCC states contributed only 16 per cent. International drug manufacturers have created a steady platform for pharmaceutical research and development (R&D) and production in Saudi Arabia and the UAE, leading to significant pharmaceuticals sector growth in these countries. Share of smaller countries is expected to increase, as they are form strategic trade relations with other nations; additionally, multinational pharmaceutical players are establishing their bases here as well.
Chart 4: Country‐wise Pharma Sales Distribution Pattern: 2010‐20
As the GCC pharmaceuticals sector develops further, regional distribution is also expected to undergo change. While Saudi Arabia’s share is likely to decline from 51 per cent to 47 per cent during 2010 to 2020, that of smaller geographies like Qatar and Bahrain is anticipated to increase marginally. Research and Development Activities set to Proliferate Currently, corporate spending on R&D as percentage of total revenue is exceptionally low in the GCC, as compared to international levels. The minimal investment here is primarily due to the small manufacturing base of local firms, low access to finance, and shortage of skilled workers and personnel. As the industry undergoes rapid expansion, it would experience significant pressure from multinational companies interested in an open drug market.
Chart 5: Share of Pharma Market in the GCC
Country‐wise Structure
Pharma
Industry
Saudi Arabia Currently, the Saudi Arabian Government is the chief financier of the GCC healthcare sector. Lately, however, it has delegated some of its financial responsibility to the private sector by introducing mandatory private health insurance coverage for expatriates since 2006. It also intends to encourage investments in the local GCC pharmaceuticals industry to boost domestic production.
Local pharmaceuticals production facilities are limited in the GCC, and Saudi Arabia (with 27 manufacturing facilities in 2009) is the clear leader. The country has opened the sector for foreign participation and taken necessary steps to provide equal opportunities to both local private and foreign companies in the sector. European and the US companies are predominant pharmaceuticals suppliers to Saudi Arabia. Other players from Japan are also positioning January/February 2016 | 10
www.middleeasthospital.com
, 1 7 ( 5 1 $ 7 , 2 1 $ /
GHFRQ
GHJUHH
WDPLQDWLRQ
ZDWHU K\JLHQH
HOHFWULFDO
ZRUOG FODVV
VSHFLDOLVW KHDOWKFDUH
GHQWDO HTXLSPHQW
WUDLQLQJ
OLIWV
H[SHUWV LQ GHFRQWDPLQDWLRQ PHGLFDO HTXLSPHQW HQJLQHHULQJ HVWDWHV )0 WUDLQLQJ KLJKO\ H[SHULHQFHG WUDLQHUV GHOLYHU UHVLGHQWLDO GD\ FRXUVHV DW VLWHV ZRUOGZLGH WUDLQ DW RXU XQPDWFKHG IDFLOLWLHV RU DW \RXU VLWH
PHGLFDO HTXLSPHQW
KHDOWK VDIHW\
EHVSRNH WUDLQLQJ GLVFRXQWV IRU JURXSV VHUYLFH DXGLWV FRQVXOWDQF\ DGYLFH
KHDWLQJ YHQWLODWLRQ
HDVWZRRGSDUNWUDLQLQJ FR XN HPDLO WUDLQLQJ#HDVWZRRGSDUN FR XN
DLU FRQGLWLRQLQJ
HVWDWHV IDFLOLWLHV PDQDJHPHQW
VWHDP
ILUH VDIHW\
PHGLFDO JDVHV
UDLVLQJ VWDQGDUGV LQ KHDOWKFDUH HQJLQHHULQJ IDFLOLWLHV PDQDJHPHQW WKURXJK H[SHUW SURIHVVLRQDO VWDII WUDLQLQJ GHYHORSPHQW
$&&5(',7('
(DVWZRRG 3DUN 7UDLQLQJ :RWWRQ XQGHU (GJH *ORXFHVWHUVKLUH */ '$ 8.
Middle East Hospital magazine
Market report
their business in Saudi Arabia and establishing joint ventures (JVs) in pharmaceutical manufacturing along with Saudi partners. For instance, Saudi Arabian Japanese Pharmaceutical Company (SAJAPHCO) is a JV between Japan International Development Organisation (JAIDO), Sankyo, Yamanouchi Pharmaceuticals, Marubeni Corporation, and Saudibased wholesaler Tamer. Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) and Glaxo Saudi Arabia are among largest producers of pharmaceuticals in the country. The United Arab Emirates (UAE) The UAE pharmaceuticals sector, which was estimated at USD 1.8 billion in 2010, is the second largest market
in the GCC. The UAE has been dependent on imported medicines, as local players lack sufficient R&D capabilities. The country, with eight domestic manufacturers in 2009, has relatively limited local production capacities. The domestic production market is ruled by generic drugs. Julphar is one of the leading drug makers in the GCC; other players include Global Pharma, Gulf Inject LLC, Medpharma, Neopharma, and PharmaCare. Kuwait Kuwait represents the third‐largest pharmaceutical market in the GCC and its market value was pegged at USD 374 million in 2010. High expatriate population and dominant presence of patented drugs, along with favourable regulatory structure, and stable polit-
ical and economic conditions drive the pharmaceutical sector’s growth in Kuwait. Only 20 per cent of pharmaceutical products, in terms of volume, were manufactured domestically in Kuwait in 2010. Kuwait‐Saudi Pharmaceutical Industries Company (KSP) is the only prime generics producer in the country. Multinational pharma firms do not have manufacturing facilities in the country, and operate through representative offices in the neighboring countries of Saudi Arabia or the UAE. Currently, the Kuwait market is dominated by imported and expensively‐priced patented drugs, as generic drugs are not widely available. Qatar Qatar, with a developing local pharmaceuticals manufacturing industry, January/February 2016 | 12
www.middleeasthospital.com
Middle East Hospital magazine
Market report had revenues of USD 227 million in 2010. Although the country has a small market size, its per capita drug expenditure is high, and a favourable structure provides better opportunities for private players. Some recent developments such as establishment of a medical device company called Qatari German Company for Medical Devices (QGMD), and a biotech research company called Scientific Medical Applied Research and Development Company (SMARD) have come about in the pharmaceuticals sector. These represent the Government’s initiatives to boost the domestic pharmaceuticals industry that would ultimately benefit Qatar’s economy. Oman According to Frost & Sullivan research, Oman is among the smallest drug markets in the GCC in terms of value. It was estimated at USD 52 million in 2010. Rising number of non‐communicable diseases is the primary growth driver of the pharmaceuticals sector in Oman. The domestic manufacturing industry is small, with only two major producers, namely, National Pharmaceutical Industries Company (NPI) and Oman Pharmaceutical Products Company (OPPC). While local drug companies produce basic products, hi‐ tech drugs are imported. Like Kuwait and Bahrain, multinationals operate in Oman through offices in Saudi Arabia and the UAE. The main suppliers include GlaxoSmithKline (GSK), Roche, Bristol‐Myers Squibb, Sandoz, Merck & Co, Pfizer, AstraZeneca, and UAE’s Julphar.
USD 118 million in 2010, as per Frost & Sullivan research. Domestic manufacturing remains underdeveloped due to limited investments and the population’s preference for high‐tech treatment facilities. Therefore, opportunities exist for private players willing to invest in a small market. Going forward, the generic sector is expected to play a significant role in market development as the Bahrain Government plans to raise health awareness and control costs. Multinational firms do not have manufacturing facilities in the country, and operate through representative offices in neighbouring countries such as Saudi Arabia or the UAE. Key suppliers to the Bahrain market include GlaxoSmithKline (GSK), Roche, Bristol‐Myers Squibb, Sandoz, Merck & Co, Pfizer and AstraZeneca, as well as the UAE’s Julphar.
Conclusion There will be lot of focus on local manufacturing in the region in the coming decade. Increased investments in manufacturing will be fuelled by newer entrants entering the market. Key areas like Diabetology, Cardiovascular and Bio pharmaceuticals will see a tremendous growth. Also there will be huge boost to the Private healthcare delivery system which will happen in the region which in turn will push the need and demand for high quality of products in the region by 2020. Author: Dr. Ajay Kumar Sharma, Associate Director, Pharma and Biotechnology Practice, South Asia and Middle East, Frost & Sullivan.For feedback/ enquiries please contact deepshrii@ frost.com/tanu.chopra@frost.com
Bahrain Bahrain’s pharmaceutical market is the GCC’s smallest, with revenues of www.middleeasthospital.com
January/February 2016 | 13
Middle East Hospital magazine
Product focus RDP Healthcare
RDP Healthcare launches new range in the Gulf
www.rdp-group.com
January/February 2016 | 14
www.middleeasthospital.com
Middle East Hospital magazine
Product focus Established in 2000, RDP Health Ltd is one of the very few UK companies that is truly customer focused, designing predominantly for the Healthcare Industry. Over the last fifteen years the company have organically grown the business by designing and then manufacturing the products that our customers tell us they need, in fact most of the products we have in our range, started life as a customer request. The only products you will find at RDP are ones that have been developed by our engineers in response to specific customer problems. Our passion is in designing and then building products that are better than those that already exist in the market, are better value, or solving a customer requirement where no suitable products currently exists at all. We do not have an expensive board of non-executive directors to maintain. Neither do we have to report to a parent company or indulge the whim of a major distributor. We are a UK company where all the shareholders are actively involved in the daily running of the company and are free to indulge our own passion, which is in understanding the problems faced by our customers. We then use a combined 50 years of design experience to solve these problems in a way that is as simple and cost effective as possible for us to build, and above all, as simple and effective as it can possibly be for our customers to use.
RDP 62 Victoria Road, Burgess Hill, West Sussex. RH15 9LR Tel +44 (0)1444 245123 Fax +44 (0)1444 245124 kbailey@rdp-group.com www.rdp-group.com www.middleeasthospital.com
January/February 2016 | 15
6140
Middle East Hospital magazine
Eastwood Park Training and ECRI Institute join forces in international healthcare market
Eastwood Park Training and ECRI Institute join forces in international healthcare market Eastwood Park Training has agreed a formal partnership with ECRI Institute. These two renowned healthcare organisations will be working closely together to improve effective asset management and maintenance of hospital medical devices, supporting each business’s ultimate mission for continued improved and effective patient safety. The leading international training provider of healthcare engineering support services, Eastwood Park, and ECRI Institute, an independent and not-for-profit organisation, which is at the forefront in applied scientific research in healthcare, have already begun working together on international projects where the strength of the two organisations will provide a unique and greatly enhanced service to customers. Equally important is the continued international presence for both businesses and the differing representations and relationships worldwide will assist the development of new products and services working together. John Thatcher, Eastwood Park’s CEO sees considerable potential with the new working arrangements: “This is a significant and important strategic arrangement for both ECRI and ourselves. We are both delighted and excited by the potential this presents for further presence and international growth particularly in the Middle East.” David Watson, Vice President of European Operations states “ECRI has always been committed to improving the safety and quality of healthcare. This strategic partnership with Eastwood Park brings together two organisations who have a significant track record in this area. I am sure our work together will make an important contribution to the healthcare community internationally.”
ECRI Institute – www.ecri.org.uk More than 5,000 healthcare organisations worldwide rely on ECRI Institute's expertise in patient safety improvement, risk and quality management, healthcare processes, medical device evaluation, procedures, and drug technology. Established in 1968 as the Emergency Care Research Institute in Plymouth Meeting, Pennsylvania, USA; ECRI Institute opened its European Office in Welwyn Garden City in the UK in May 1995. Eastwood Park Training Renowned worldwide for its delivery of specialist technical engineering and estates and facilities management training within the healthcare sector, Eastwood Park delivers its training worldwide and at all levels. Established in 1969, it was formerly the National Centre for Hospital Engineering for the Department of Health (NHS) and today is independently run with a significant and unique multi-million pound stateof-the-art training centre under construction in the UK for 2016.
www.middleeasthospital.com
January/February 2016 | 16
6140 Vibro watch A4 leaflet:Layout 4
10/2/10
14:06
Page 1
Come and see us at
Arab Health Stand Z1 C30
Vibro-Watch + Record ©
The world’s one and only Multifunctional Vibrating Alarm Watch with recordable messages prolongs independent living at home ● ● ● ● ●
12 independent specific-time vibrating alarms 12 recordable messages for each of the specific-time selections Periodic auto-repeat vibrating alarm with recordable message Ability to select vibrating alarm with or without message No loss of programme information while changing battery
For use with:
● Dementia, Alzheimer’s, Autism, the Elderly,
People with Special Needs, Memory Loss & Diurnal Enuresis
Timed Voiding, General Daily Routines (eating, drinking etc.), Appointments, and Behavioural Modification Programmes
and Inno vat alth He io rd wa nA
● Taking Medication, Bladder Emptying,
MEH 201 5
Reminder for:
Official Nominee for 2015 Awards
Description
The Malem© Vibro-Watch© + Record is a digital multifunctional watch with 12 independent specific-time vibration alarms and a specific auto-repeat vibrating alarm (range from 1 minute to 23:59 hours). Each of the selectable vibrating alarms can be accompanied with a specific recorded 10 second message. The Vibro-Watch© displays real time in hours (12/24, am/pm), minutes, seconds, month date, day of the week and also has a stop watch. Any of the set vibrating alarms can be accompanied with the recorded message. Selected specific-time or periodic auto-repeat vibration/message alarms can be easily activated or de-activated (on or off ). All programmed information is held in permanent memory so no information is lost while changing the battery.
Malem Medical
10 Willow Holt, Lowdham, Nottingham NG14 7EJ, England, UK Tel: + 44 (0)115 966 4440 Fax: + 44 (0)115 966 4672 E-mail: malem@malem.co.uk Web: www.malem.co.uk Web: www.malemmedical.co.uk © Malem Medical 2010
Model MO16
Middle East Hospital magazine
Arab Health 2016
Arab Health 2016 Preview
January/February 2016 | 18
www.middleeasthospital.com
Middle East Hospital magazine
Arab Health 2016
Established over 40 years ago, the Middle East Diabetes Conference Arab Health Exhibition and Experts at Arab Health 2016 will Congress provides a platform for review the latest published Diabetes the world’s leading guidelines for 2016 and will argue manufacturers, whole-salers and that collective action from distributors to meet the medical private and government sectors is and scientific community in the required to address economic impact Middle East and beyond. Arab of unman-aged diabetes epidemic Health, organised by Informa in the UAE. This issue will be Life Sciences Exhibitions, takes debated at the Middle East Diabetes place from 25-28 January 2016 Conference taking place for the first at the Dubai International time during Arab Health. Convention and Exhibition Centre. With more than 4000 One of the most pertinent effects of companies from the global diabetes epidemic, besides exhibiting over 60 countries, and 19 the devastating health consequences accredited medical for people with unmanaged diabetes, CME conferences, Arab Health is is its economic impact. Patients diaga much anticipated addition to nosed with diabetes, on average, have the 2013 medical event calendar medical expenditures that are approxin the Middle East region. www.middleeasthospital.com
imately 2.3 times higher than healthy individuals. According to a recent report by Booz Allen Hamilton, the increased cost of diabetes in the United Arab Emirates (UAE) associated with demand for specialized services will increasingly and disproportionately impact the government’s healthcare expenditure over the next 10-15 years. According to Dr. Maha Barakat, Medical & Research Director of the Imperial College London Diabetes Centre (ICLDC), Abu Dhabi, and speaker at the Middle East Diabetes Conference, “ICLDC believes that a solution must first be found to understand why the problem of diabetes exists within the UAE, secondly the existing problem must be tackled in January/February 2016 | 19
Middle East Hospital magazine
Arab Health 2016 terms of world-leading treatment to prevent and manage complications, and thirdly to prevent diabetes from developing in the first place in individuals who are at high risk. Unfortunately the solution cannot be provided by one small clinic, a group of community practices, or the endocrine department of a particular hospital; the numbers of patients are simply too great.” Dr. Barakat will also be reviewing the latest Diabetes guidelines as published by the American Diabetes Association (2015 Consensus Statement), as well as the International Diabetes Feder-ation (Global Guideline for Type 2 Diabetes 2015), and Global Guideline for Management of Post Meal Glucose in Diabetes 2015. The UAE ranks tenth worldwide for the prevalence of diabetes per capita of the adult population; recent figures from the International Diabetes Federation (IDF) suggest that 19.2 per cent of the UAE adult population is living with diabetes, half of whom are unaware that they have it. According to the October report Allen Hamilton by Booz titled “Exploring the Growing Challenge of Diabetes Across the GCC and Within the United Arab Emirates”, the burden of diabetes is straining the UAE’s financial resources and incur-ring societal costs. The analysis found that in 2015, the total cost of diabetes in the UAE (including healthcare costs and both mortality- and opportunity disability-re-lated costs) was nearly $8.6 billion (AED 30 billion) or 1.8 percent of GDP, higher than in any other GCC country. January/February 2016 | 20
www.middleeasthospital.com
ME PSQ
Save Money & Time Use Malem Alarm
Come and see us at Arab Health Stand Z1 30
For the PERMANENT Cure of Bedwetting NICE
(National Institute for Health and Clinical Excellence)
Recommend: The Use of The Enuresis Alarm as FIRST-LINE Treatment
Improve Your Service Save Money and Time
Use The Malem Enuresis Alarms Malem Medical: 10 Willow Holt, Lowdham, Nottingham, NG14 7EJ, England, UK Tel: 0115 9664440 Fax: 0115 9664672 email: malem@malem.co.uk www.malem.co.uk
Middle East Hospital magazine
Arab Health 2016 Direct diabetes treatment constitutes approximately 40 percent of the nation’s overall healthcare expenditure. The estimated annual costs attributed to diabetes in the UAE are forecast to increase to as much as $1.04 billion (AED 3.82 billion) by 2020, representing a 58percent increase from an estimated $657 million (AED 2.41 billion) in 2010. Grant McLaughlin, Vice President, Booz Allen Hamilton highlighted that, “Unless action is taken immediately, even larger numbers of people in the UAE will continue to be impacted by diabetes. It is vital that the private sector, which is greatly impacted by the costs of providing insurance and of lost employee productivity, play a critical role within the country to take collective action across society to address this growing public health issue.” Respiratory, Critical Care and Sleep Diseases Conference Sepsis is one of the topics to be discussed at the 3rd Respiratory, Critical Care and Sleep Diseases Conference taking place at Arab Health Exhibition & Congress 2016 from 30 - 31 January in Dubai, UAE. The CME accredited conference will look at the latest information pertaining to the diagnosis, management and treatment of pulmonary disorders, chronic respiratory disease and critical patient care in the Middle East region. Sepsis, a condition characterised by a whole-body inflammatory state that is triggered by an infection, has been a major concern for many physicians globally and is now being highlighted as a concern within critical care circles in the Middle East. Public awareness January/February 2016 | 22
www.middleeasthospital.com
Safety on journeys ON CONCESSIONARY TERMS
we e k s , mont hs or e ve n ye ar s or you are e x p e c t in g f ore i gn gu e s t s and e mploye e s? O ur s h o r t - t e r m an d l o n g - t e r m h e alt h in sur an c e f o r t r a v e l s ab r o a d of f e r s the optimal p rote c tion . It c an b e e x te nde d by an e me rge nc y, liabilit y, tra ve l acc ide nt or a b aggage insurance . We o f f e r t h e s u i t a b l e p a c k a g e f o r y o u i n a n y c a s e . Choose which need C ho ose the the ssituation ituation ffor or w hich yyou ou n e e d a ttravel ra ve l iinsurance: nsurance : ✔ ✔ ✔ ✔ ✔ ✔ ✔
Vac ationist s A u - p a ir s , p u p il s & s t u d e n t s F o r e i gn gu e s t s G r o up s B u s in e s s t r a v e l e r s & e x p a t r ia t e s Eve n t s F o r e i g n m e di c al p r a c t i t i o n e r s
Ham b ur g H e al t h C o n s ul t an t s · R e in h ar d H o llun d e r · M an a g in g D ir e c t o r G e r t r u d e n s t r a ß e 3 · 20 0 9 5 H a m b u r g · i n f o @ h a m b u r g - h e a l t h - c o n s u l t a n t s . c o m w w w.hamburg-health- consultants.com · Phone: 0049 40 32 32 07-20 · Mobile phone: 0049 175 5800 880
■ CURIOUS? VISIT OUR WEBSITE: www.hamburg-health-consultants.com
■ QUESTIONS? PROBLEMS? INFORMATION? Please contact our Managing Director, Mr. Reinhard Hollunder, cellphone +49 175 5800 880 or send us an Email: info@hamburg-health-consultants.com
■ AND DON’T FORGET: You can meet us at our exhibition stand during ARAB HEALTH 2015, Dubai/ UAE, Zabeel Hall
First-class health - made in Germany
Middle East Hospital magazine
Arab Health 2016
about this serious condition is still low. Physician awareness is also still below the targeted level in this region so campaigns to increase the knowledge and awareness among physician practicing in this region have to be carried out first. Severe sepsis is a very serious condition, which is usually treated in the intensive care unit with intravenous fluids and antibiotics. This inflammatory response is driven by reaction of our immune system to pathogens (like bacteria) in the blood, urine, lungs, skin, or other tissues. Sepsis patients usually require preventive measures for deep vein thrombosis, stress and pressure ulcers, unless other conditions prevent this. A good control of blood sugar levels, occasionally requiring treatment with intravenous
insulin is one of the cornerstones of treatment, hence its importance in the Middle East which is home to six out of the world’s top ten countries for highest prevalence (%) of diabetes. According to Dr. Amro Alastal, pulmonary, critical care and sleep medicine consultant at the American Hospital Dubai and Advisory Board member for the 3rd Respiratory, Critical Care and Sleep Diseases Confer-ence at Arab Health 2016, “Mortality rates as a result of sepsis (also known as blood poisoning) have been increasing over the past 20 years. This is a very alarming phenomenon and must be controlled. We are lucky that are various measures that can be taken to treat it, however, caution must be exercised at all times when assessing a patient for potential sepsis.”
“There has been a large increase in sepsis as a result of introducing strong medication that suppresses the immune system,” explains Dr. Alastal. “These medications are used to treat patients suffering from cancer or who have undergone organ transplant surgeries, for example. The administration of antibiotics has increased in the region and unfortunately many strains of bacteria have become resistant to antibiotics, making the treatment of sepsis more difficult in some cases. In the past, these patients would have died due to complications of their disease but as time progresses we get better at treating the underlying illness itself, and patients survive longer as a result; however in some cases they die due complications of the therapy itself.” January/February 2016 | 24
www.middleeasthospital.com
Middle East Hospital magazine
Physicool launches new Product Range for Gulf Physicool is a leading British company that has developed an eviable product range and award winning brands. Physicool has now become a household name used by world-renowned surgeons, elite athletes and every-day people alike. The products are used throughout Africa, America, Asia, Australia, and Europe for every-day purposes ranging from the treatment of a sprained ankle, enhancing patient rehabilitation post surgery to beating the heat of a hot flush.
Physicool origins stem back to the equine market, Physicools sister company Equinice, and a small office on a Dorset farm, England. Physicools rapid evaporation cooling system was initially used to treat race horses. It wasnt until we received feedback from jockeys using Physicool to treat their own injuries that we realised the human application. After testing and product development Physicool was born, Physicool shot to stardom in 2009 when Kay pitched Physicool on BBCs Dragons Den. On the night of that successful pitch their website received 36,000 visits and global interest.
Today the company continue to grow product offerings with the development on new products and applications Physicool CEOKay Russell including the new Cooling Mist range successfully launched at Medica. Physicool is dedicated to enabling people to live their lives to the fullest by providing intelligent, forward thinking medical devices and lifestyle products to aid wellbeing to recovery. www.physicool.co.ukyToday the company continue to grow product offerings with the development on new products and applications including the new Cooling Mist range successfully launched at Medica. Physicool is dedicated to enabling people to live their lives to the fullest by providing intelligent, forward thinking medical devices and lifestyle products to aid wellbeing to recovery.
Contact Kay Russell Tel 0044 7778274265 kay@physicool.co.uk www.physicool.co.uk
Physicool CEO Kay Russell www.middleeasthospital.com
January 2016 | 25
L130/135
Tablet computers designed for healthcare Integrated front & rear cameras 10.1”
Programmable hotkeys
Multi-touch screen with digitizer
MicroSD™ card slot
NFC user authentication
Optional Power / Data cradle
1.2 m
Hot-swap battery
1.2m drop resistant MIL-STD-810G
IP67 sealed and disinfectable
Connectivity*
Professional integrated 1D/2D Barcode Scanner* * Available on the L135 model only.
Connected anywhere Designed for healthcare
Redundant connectivity with 3G*, WiFi and Bluetooth® 4.0 + EDR
Integrated barcode scanner* and cameras. Wipe with alcohol to disinfect.
Robust design
Secure Supports access control using smartcard authentication with in-built NFC reader and HF RFID tag reader.
IP67 ingression protection / 1.2 metre drop resistant.
For further information contact us on: +44(0)1293 566291 • Email: julian.stone@mio.com website: miocare.mio.com
Tablet computers designed for healthcare
L130/135 The L130 series from MioCARE are high performance tablets for healthcare professionals. Featuring an IP67 ingression-resistant housing that can be wiped with alcohol for infection control and MIL-STD-810G drop resistance to concrete, the L130 series is designed for the healthcare environment. The integrated 1D/2D barcode scanner* supports positive patient identification and the hot swap battery provides uninterrupted use 24/7. The L130 series is secure for healthcare. Two factor authentication is delivered through integrated NFC or optional USB smartcard accessories. Optional mobile device management (MDM) solutions enable full control over applications, encryption, connectivity and more on a single or group user level. With integrated WiFi, Bluetooth® 4.0 and 3G*, the L130 series offers always-on connectivity in all environments. Retrieve patient data, view lab results in real time and communicate with clinical team members using the integrated cameras and microphone.
System
Designed for healthcare Integrated barcode scanner and cameras. Wipe with alcohol to disinfect. Hot swap battery for uninterupted use.
Screen:
10.1" Capacitive multi-touch, WXGA (1280 x 800) with digitizer, 600 nits
OS: Processor:
Android™ 4.2.2 Texas Instruments ARM Cortex-A9 Dual-Core OMAP4470 @ 1.5GHz 6720mAh capacity, up to 8 hours operation, user-replaceable, hot-swap 1GB Internal 16GB Expandable: MicroSD SDHC up to 32GB
Battery: RAM: Memory:
Secure Supports access control using smartcard authentication with in-built NFC reader and HFRFID tag reader. Optional MDM solutions.
Connected anywhere
Wireless 802.11 a/b/g/n, Bluetooth® 4.0 + EDR, Integrated 3G* Input: USB Type A & Type B (microUSB) Barcode scanner: 2D/1D Imager* Sensor: Temperature, light, accelerometer, GPS* Environment: IP67, 1.2M drop resistant, MIL-STD-810G compliant
Redundant connectivity with 3G*, WiFi and Bluetooth® 4.0 + EDR.
Camera: Audio:
Rear 5.0Mp AF with flash / Front 1.2Mp FF Stereo speakers, 3.5mm jack, microphone
AC mains:
In: 100~240VAC Out: 5VDC, 2A DC jack
Operating temperature:
-10 to +50°C
Certification: Warranty:
CE/CB - CE (R&TTE), FCC, NCC/BSMI, CCC, IP67 12 months (extended warranty available)
Weight:
Approximately 950g
Robust design IP67 ingression protection and 1.2 metre drop resistant. MIL-STD-810G compliant.
©2014 MiTAC Intl. All rights reserved. Android is a trademark of Google inc. All other trademarks are the property of their respective owners. All specifications are subject to change without prior notice.
Connectivity:
* Available on the L135 model only.
For further information contact us on: +44(0)1293 566291 • Email: julian.stone@mio.com website: miocare.mio.com MiTAC Europe, Spectrum House, Beehive Ring Road, Gatwick, West Sussex RH6 0LG
Middle East Hospital magazine
SIDHIL LEADS WITH INNOVATIVE PRODUCT DEVELOPMENTS FOR ARAB HEALTH Healthcare specialists Sidhil plan to make a real impact at Arab Health in January 2016. The company will be demonstrating an exciting range of innovative products for the very first time in this marketplace, with developments which signpost the future for modern hospital care. On show will be the brand new Innov8 iQ ward bed with split siderails, designed to meet the everincreasing challenges of the hospital environment and satisfying the highest standards for safety and reliability. This high specification bed is now suitable for specialist areas and high dependent CCU and HDU patients as well as general ward applications, and features a brand new development in the shape of electronic castors, achieving new levels of safety and performance. Designed with patient safety in mind, the new bed features a low mattress platform height to assist with falls prevention strategies. The side rails are cleverly designed to drop to a lower level than the mattress platform, ensuring patient egress and ingress is safe and unhindered, whilst built-in dampers ensure they lower at a measured rate for maximum levels of safety. Alongside the Innov8 iQ, Sidhil will also be demonstrating a totally new development in the fight against pressure ulcers, never seen before in the Middle East. M.A.P™ (Monitor, Alert, Protect) is an intelligent pressure distribution monitoring system using a pressure sensing mat to provide 24/7 data on pressure levels developing between the patient and the support surface.
The outer layer of this mat consists of a medical grade biocompatible material which houses thousands of sensing points capable of accurately imaging the body of the patient lying on the support surface. This information is sent to a monitor attached to the mat, where it is displayed as a real time, colour coded high resolution image, with areas of high pressure clearly delineated in red and orange, and lower pressure areas showing as green and blue. This real time visual ‘pressure map’ gives care staff accurate detail on each individual patient, enabling them to alter the patient’s position accordingly to reduce pressure and therefore reduce the potential for pressure ulcers. Micro movements can reduce pressures dramatically, which is particularly effective for patients where full body repositioning or even turning may be restricted. Also on show will be Sidhil’s Inspiration cot together with the company’s brand new crib designed specifically for newborns, with a range of safety features and positional options
Sidhil looks forward to welcoming representatives from the company’s growing Middle Eastern distributor base to the stand, meeting up with existing and new customers and talking through the benefits of the latest products with clinicians. In 2015, export sales represented a growing percentage of total turnover, with a developing network of established distributors around the world, and export sales targeted to total 20-30% of turnover within five years. Sidhil remains totally committed to UK manufacture and is a key supplier to the NHS in the UK. The company enjoys established and ongoing sales in several of the Gulf States including Saudi Arabia, United Arab Emirates and Oman, and has sold thousands of hospital beds into Saudi Arabia. In just one order, the company delivered 900 bariatric plinths – electrically
www.middleeasthospital.com January 2016 | 28
Middle East Hospital magazine
ARAB HEALTH 2016 - PRODUCT FOCUS SIDHIL Sidhil remains totally committed to UK manufacture and is a key supplier to the NHS in the UK. The company enjoys established and ongoing sales in several of the Gulf States including Saudi Arabia, United Arab Emirates and Oman, and has sold thousands of hospital beds into Saudi Arabia. In just one order, the company delivered 900 bariatric plinths – electrically operated couches designed specifically for the heavier patients in society – filling 19 containers!
The outer layer of this mat consists of a medical grade biocompatible material which houses thousands of sensing points capable of accurately imaging the body of the patient lying on the support surface. This information is sent to a monitor attached to the mat, where it is displayed as a real time, colour coded high resolution image, with areas of high pressure clearly delineated in red and orange, and lower pressure areas showing as green and blue. This real time visual ‘pressure map’ gives care staff accurate detail on each individual patient, enabling them to alter the patient’s position accordingly to reduce pressure and therefore reduce the potential for pressure ulcers. Micro movements can reduce pressures dramatically, which is particularly effective for for patients where full body repositioning or even turning may be restricted. Also on show will be Sidhil’s Inspiration cot together with the company’s brand new crib designed specifically for newborns, with a range of safety features and positional options. Sidhil looks forward to welcoming representatives from the company’s growing Middle Eastern distributor base to the stand, meeting up with existing and new customers and talking through the benefits of the latest products with clinicians. In 2015, export sales represented a growing percentage of total turnover, with a developing network of established distributors around the world, and export sales targeted to total 20-30% of turnover within five years.
Come and see us in Zabeel 1 Stand ZG51 For further information, please contact Sidhil on the following: sales@sidhil.com / +44 (0) 1422 233 000 / www.sidhil.com
www.middleeasthospital.com
January 2016 | 29
Middle East Hospital magazine
GCC Breaking News Mitac Miocare Healthcare tablet range & System Nominated for MEH Award Miocares Healthcare tablets range has been nominated for a prestigious Health and Innovation 2015 award for by Middle East Hospital (MEH) magazine.
Mike Tanousis, MEH Publisher, said, “The Miocare tablet range and system solutions are a powerful & innovative addition and is a strong contender for this year’s award in the innovative healthcare innovation and software category as it has the potential to make a significant contribution to healthcare in the Middle East. Miocares dedicated R&D team has developed the range over a 5 year period, in Taiwan the Middle East, and Europe.” Julian Stone EMEA Director, said, “It is a great honour for us to nominated for a prestigious Health and Innovation 2015 award for our Miocare Tablet range system by MEH magazine. Miocares’ dedicated team is continuously working to provide a world class tablet and application plat-forms to physicians, clinics,pharmacies hospitals, and corporates."
The L130 series is secure for healthcare.Two factor authentication is delivered through integrated NFC or optional USB smartcard accessories. Optional mobile device management (MDM) solutions enable full control over applications, encryption, connectivity and more on a single or group user level. With integrated WiFi, Bluetooth® 4.0 and 3G*, the L130 series offers always-on connectivity in all environments. Retrieve patient data, view lab results in real time and communicate with clinical team members using the integrated cameras and microphone. Tablet computers designed for healthcare Integrated barcode scanner and cameras. Hot swap battery for uninterupted use.
The L130 series from MioCARE are high performance tablets for healthcare professionals. Featuring an IP67 ingression-resistant housing that can be wiped with alcohol for infection control and MIL-STD-810G drop resistance to concrete, the L130 series is designed for the healthcare environment. The integrated 1D/2D barcode scanner* supports positive patient identification and the hot swap battery provides uninterrupted use 24/7. rrupted use 24/7. The L130 series is secure for healthcare.
www.middleeasthospital.com
January 2016 30
1
Distributors
Wanted Exciting new opportunities
C
M
Y
CM
MY
CY
CMY
K
The UK's leading manufacturer and supplier of long lasting adjustable treatment couches. • Manufactured in the UK • Lifetime guarantee on frame • 5 year guarantee on components • Friendly, attentive export team to assist you • Full training and marketing support.
Contact us today, call
+ 44 (0)1449 767 887 Or visit us online www.plinth2000.com
Approved Supplier
ST.
ER FA
which draws heat out of sprains, strains and other sport injuries by rapid evaporation. The cooling effects is much more effective than ice packs, sprays or gels, getting you back
on your feet fast! COOLING + COMPRESSION = HEALING Rapidly reduce pain, swelling and inflammation Easy to apply Does not require refrigeration Reusable and washable Clinically proven results Helps speed up recovery
Please visit www.physicool.co.uk for more information. PID EVAP RA
CH
Y
T
E
ATION OR
UNIQUE
D R A WS H E A T A N D I N
F LA
TIO MMA
N OU
C OV T. RE
Physicool is a unique therapeutic bandage
N O LO
G
Rapid Relief, Rapid Recovery
Come and meet us at Arab Health contact Kay Russell 0044 7778 274265 kay@physicool.co.uk Skype kay-russell
CONTINUOUS PROFESSIONAL DEVELOPMENT AND SHORT COURSES DEPARTMENT OF
Visit us at Arab Health 2016 Contact Samir Zreik Tel 0044 7710452480 email samir@plinth2000.com
Middle East Hospital magazine
Review
Abu Dhabi Middle East Review The 3rd Annual World Health Care Congress Middle East (WHCC ME), co-sponsored by the Health Authority Abu Dhabi, the premier conference in the region, brought together over 600 health care, government and industry leaders from over 25 countries. H.E. Zaid Al Siksek, CEO of HAAD, said: “The Emirate of Abu Dhabi is pursuing a prominent position on the global health care map through the continuous improvement of healthcare services and provision of health according to the highest global standards, in addition to attracting expertise and financial investment to the sector.”
Dr Ali Yemeni – Deputy Minister of Health Saudi Arabia
“HAAD is building a healthcare system for the people of Abu Dhabi, where all nationals and residents living or working in the Emirate have access to affordable quality healthcare services”, H.E. added. According to HAAD statistics for 2011, an aggressive growth in demand is expected for services relating to lifestyle diseases like diabetes, cardiovascular diseases and cancer with larger volume increases in outpatient settings.
Arpan David, RAK Hospital, Barbara Sanchez, Patty Ziomek & Bob Ziomek, QHM
In terms of supply the number of physicians in the Emirate has witnessed a 3 per cent growth, and 11.8 per cent of growth in facilities. High demand projections also indicate that in 2012 demand for inpatient services may require 1600 additional beds beyond the current 3,659 beds. However, investors hold 42 preliminary hospital licenses which signal significant future capacity to meet this demand.
The Aviir Team
January/February 2016 | 36
www.middleeasthospital.com
Middle East Hospital magazine
Review The capacity gaps section of the statistics report confirms that waiting times have been reduced across most specialties. There is a critical capacity gap in intensive & critical care medicine and overall gaps remain in emergency medicine, neonatology, cardiology, psychiatry, paediatrics and oncology. Significant new capacity is however anticipated in paediatrics and gynaecology.
Hakan of Florence Nightingale Hospitals; Dr Nadia Cheaib, Clinserv; Mike Tanousis, MEH Publisher
Overall bed occupancy rates vary by facility, but have significantly decreased in aggregate indicating reduced efficiency. Be d oc cupancy in ICU, NICU, PICU, CICU, CCU and isolation was consistently over the optimal 75 per cent during 2015.
Zaid Al Siksek, CEO, Blue Apple
There were keynote speeches from Zaid Al Siksek focusing on disease management and especially Diabetes as well as some powerful presentations from dynamic and inspirational Walid Fitahi, CEO of IMC Hospital Jeddah, and a very frank and revealing insight from Ali Yemeni the Deputy Minister of Health for Saudi Arabia on the state of Saudi healthcare and its provisions and planning more the massive growth and expansion over the next 15 years with a spend of over US$60 Billion. The event was brilliantly compered by the charismatic and knowledgeable Riz Khan: “It is a great forum. Very essential in bringing people together to understand more about the different health systems in view of the current financial issues. It will open the venue to search for research projects and models of collaboration.� There were interesting and stimulating talks by Dr Nadia Cheaib (CEO Clinserv), Maha Barakat from Imperial College),Javid Sheikh from Weil
Jahved Sheikh, CEO, Weil Cornell; Dr Mohammad Alkhazim, King Saud University; Dr Mussaad Al-Razouki, Kleos Corp
www.middleeasthospital.com
January/February 2016 | 37
The first healthcare focussed specialist company offering bespoke solutions that can be adapted to the needs of each individual ward in the hospital.
ANDROID
SECURE
The MioCARE series uses Android™, the world’s most popular mobile operating system. Android™ is a flexible and open development environment which allows choice for interfaces and systems. MioCARE provides advice and solutions regarding an appropriate level of security for each application.
We have developed a suite of complementary solutions to provide varying security options which significantly reduce the risk of theft associated with consumer tablets. These include partnering with mobile device management providers to remote wipe the products, log on options for secure access and single app lock out configuration. Full two factor authentication is available.
INGRESSION PROTECTION MioCARE offers devices in two levels of liquid ingression resistance. The MioCARE IP54 range is splash and shower proof, whilst the MioCARE IP67 range permits zero dust ingression and is 1 metre submersible for up to 30 minutes – both idea for healthcare professionals working in the most testing of environments.
Android™ tablet with enterprise-grade technology designed to accompany healthcare professionals in their environments
MioCARE L130 Series
Middle East Hospital magazine
Special feature
The Brand Power Good Branding Is Good Business In the bygone days of the old west, a cattleman would put his identifying mark on his livestock. Simple, but effective. By extension in modern marketing, it's much the same concept, but not nearly as simple. These days, it means putting your identifying mark on just about everything that means business. “Brand” is commonly defined as a company’s personality and it embodies tangible and intangible qualities that create value; it influences both how an organization functions and how it is perceived, internally and externally. From a marketing or consumer perspective, it is the promise and delivery of an experience; from a staff perspective, it is a culture and mission; from a business perspective, it is the security of future earnings; and from a legal perspective, it is distinct intellectual property. Like a consumer brand, healthcare brand is a direct representation of the practice which meaningfully differentiates it from others in its category thus making it for who you are, what
you stand for, and how that information is communicated to others, as a total identity. This identity formed gets wrapped up into a strategic combination of logo, slogan, service, promise and much more, called BRAND. The act of brand building refers to the deliberate and skillful effort to create a desired perception in the mind of the patients, which if positive will further help to attract new patients, increase physician referrals and building business partnerships. In today's complex and competitive healthcare environment, brand and reputation are much more important to organizations than ever before. Initiatives focused only on improving clinical procedures weren’t enough to keep patients satisfied, or to lure them away from competitors. The hospitals will have to move beyond their traditional sphere of merely providing medical care and must put in place the operations and processes to satisfy patients through differentiated experiences that engender greater loyalty. Exceptional patient experience has the potential to radically improve
the patient’s perception about the hospital and strengthen the brand reputation. The staff, the physical environment, the clinical practice and the service delivery, collectively represent the 'patient experience. The full impact of branding is not just a matter of what you say in your latest series of newspaper ads. It is about the tone, the voice and how the staff communicates and interacts with its community to create a meaningful and memorable patient care experience. For such a cultural shift to take place, employees need to understand the brand, believe in it and appreciate their role in the patient experience. January/February 2016 | 40
www.middleeasthospital.com
Middle East Hospital magazine
Special feature
Because if the staff isn't buying the branding message, then the patients aren't going to get the message or the experience that is actually intended. Hence all employees and associates must “live the brand” with every customer interaction, demonstrating a team oriented, collaborative approach to patient care. There are formidable and quantifiable examples of Healthcare branding which have reaped impressive rewards, including Mayo Clinic – Minneapolis, MN, M.D. Anderson – Houston, TX, Apollo Hospital in India, NMC Hospital in Abu Dhabi, UAE
Measuring the Brand Power Despite having rankings for almost everything imaginable in healthcare like largest hospital, busiest hospital, best hospitals, best places to work and more but still there are many ambiguity about how to measure and rank hospital brands. But by believing in the notion that a hospital's brand is largely experientially based, there are many metrics that can help to illuminate the power of the brand. Here is the list of brand indicators • Patient satisfaction: Ultimately the brand hinges on patient satisfaction. A patient’s perception of how they've www.middleeasthospital.com
been treated during an event can have a greater impact on their future behavior and loyalty more than the actual outcome of the event. It’s even imperative to deal with disgruntled customers and use the opportunity to convert an upset patient into a brand loyalist who sings the hospital’s praises. A satisfied patient will act as a brand ambassador because people trust their friend’s and associate’s recommendations, which give them the confidence about the services. Word of mouth marketing is one of the most effective, genuine and reliable way of branding, because here customer shares his experience directly. January/February 2016 | 41
Middle East Hospital magazine
Special feature • Physician satisfaction is also a powerful metric to correlate with brand power. Physician satisfaction is a quality measure that affects treatment outcomes. A patient’s perception of physician friendliness and caring can affect patient satisfaction. • Employee satisfaction: Employees are the most important overarching and own able asset a company can leverage to transform itself in the market and establish a dynamic relationship with its audience. Hospital Employees are on the frontlines, shaping patient experiences, and bringing a hospital’s message into communities. The ability to turn the employees into brand ambassadors is a best strategy. Confused employees are a major detriment to any organization, especially hospitals. Brand Challenges 1. Healthcare branding is a unique entity in itself with its sensibilities completely different from other service oriented industries. Hence, the first challenge is to carefully develop brand in a manner that it not too commercial and retains its human element. 2. Now, in the face of shrinking reimbursements, rising operating costs, and a rapidly changing healthcare culture and treatment system, hospitals must rethink their delivery of superior and cost-effective care if they are to be successful in the future. Any form of branding that encourages increased resource use and increases the costs of care is inherently in conflict with ethical medical care. 3. Another challenge is when a doctor becomes larger than the brand. There
is no denying that people have traditionally preferred to visit Doctors who are famous, not really paying much attention which hospital they are attached to. But since now branding has become the important ingredient of any hospital strategies, it’s a chal-
lenge to actually differentiate whether it is the preeminent doctors who is pulling in the patients or it is the hospital as a brand. 4. Budgets for branding are always seen with a sour eye. In a tough economy January/February 2016 | 42
www.middleeasthospital.com
Middle East Hospital magazine
Special feature spending to increase patient revenue or save to keep the practice afloat, is an equally tough and challenging decision. 5. It's even more challenging is to measure the ROI from branding initiatives. While real relationships are a valuable way to measure the brand power. ROI, measuring the success of a new branding campaign should include the number of eyeballs shakes and finger swipes, the number of conversions, calls, responses and recommendations. 6. Unfortunately, the laudable era of openness and encouragement of patients to voice their dissatisfaction has also led to high and perhaps unrealistic expectations, which is compelling the hospitals to maintain a fine balance between their promises and delivery. 7. Regulatory compliance that continues to exist in the healthcare industry plays a pivotal role in the adaptation of healthcare branding. 8. Even when hospital competes on innovation, new products or enhanced services, they still quickly become undifferentiated in the minds of patients as competitors continue to match their latest and greatest features. Conclusion While everyone knows that a hospital is a place of pain and anguish and trade in, the matters of life and death and other emotional concerns and services beyond standard business paradigm, the hospital or healthcare branding must go far beyond just a new logo or slogan and must essentially encapsulates the human element that is consis-
tently articulated, developed and delivered. And while hospital customers are not always customers by choice, choice is playing an ever-greater role in where and how they get care.
Healthcare branding is a powerful business tool that, if strategically defined and creatively expressed, has the ability to galvanize and inspire patients.
A confident and differentiating healthcare brand not only helps in shaping the customer's choice of brands but also help to attract and retain exceptional staff who will further help to attract and retain patients, which will in turn perpetuate the brand’s differentiation and strength.
The essence of branding is about the reputation; it’s about keeping promises and creating great experiences. Just to rephrase Marty Neumeier “Your brand is your patients’ gut feeling about you and your hospital. It’s not what YOU say it is. It’s what THEY say it is”. By defining and applying brand consistently across every touch point, from the first phone call, to the initial visit, to the chair side conversation, the healthcare branding has the ability to galvanize and inspire patients and drive business performances.
And because branding is the sum total of the entire experience the patients have in the hospital including the staff and even the physical office environment—it's best to understand that branding begins with the proper alignment of literally everything from the inside outward. Social media have the potential to revolutionize the healthcare industry and so the healthcare marketers must adopt social media as an important component of their marketing strategies. Social media is a unique opportunity to humanize a brand, to create a brand personality and to connect the brand to their potential consumers. The network effect of social media can cause these word-of-mouth experience stories grow exponentially and seen by far more people and in far more places. Plus it allows others to view the conversation days, months and even years after it took place It is also important for the healthcare industry to have an identity of its own to ensure that patients aren’t misled by faulty information. If a brand personality is not created deliberately, one will be created by default or by accident, which may not be the one desired. www.middleeasthospital.com
About the Author Praveen Pillai is a Health care management professional with over 11 years of progressive experience in national & international markets. His management career has ranged from senior management of hospitals and medical care services, to entrepreneurial business development and management. Involved in conceptualizing and successfully developing pioneer healthcare models as well as innovative products and services including concierge practice, home health care & on-site clinics. Praveen is a candidate for a doctorate program in Business Management. He is a graduate in Business Economics (MBE) from School of Economics, DAVV, INDIA & holds a Masters diploma in Hospital & Healthcare management from Symbiosis INDIA.
January/February 2016 | 43
Middle East Hospital magazine
UAE News UAE-Based Healthcare Group To Invest Dh 2,204m In Expansions DM Healthcare, a leading healthcare group in the UAE, is all set to expand its healthcare business by diversifying into pharmaceutical and medical equipment manufacturing apart from opening two more mutli-specialty hospitals in the next two years.. Speaking to 'Emirates24|7' on the occasion of the silver jubilee celebrations of DM Healthcare, Dr Azad Moopen, Chairman, DM Healthcare, said, the group has charted out a road map for expansion until the year 2025. And in the next five years, the group will invest $600 million (Dh2,204m) for its expansions into new geographical areas such as Europe, America and African countries and to expand its presence in the GCC and India through mergers and acquisitions, he added. The two Silver Jubilee Aster Hospitals will be located at Mankhool Bur Dubai, in Dubai, and King Faisal Street in Sharjah. They will offer stateof-the-art facilities. The hospitals will also provide super-specialty clinics. The hospitals are scheduled to begin operations in the last quarter of 2014. The group has also launched a network of budget-model clinics called Access Clinics in the UAE, which caters to the low-income residents. A multibillion dollar group which started with just one clinic in the UAE 25 years ago is also contemplating more diversification into vertical areas of producing lifesaving medicines, especially off patent generic medicines and medical equipment, in view of the anticipated demand from the UAE, Gulf, India and other international markets.
This is the first time that the healthcare service company is foraying into manufacturing. “It is a logical conclusion that we enter into new vertical areas of healthcare business like manufacturing of drugs and pharmaceuticals and medical equipment. We have started business from the UAE and our intention is to become a truly global healthcare company,” he said, adding that the location of the proposed pharmaceutical manufacturing unit is yet to be considered. The GCC, India and the African countries are being considered, he added. Announcing the launch of 'Care Beyond Boundaries' initiative, Dr Moopen said: “We aim to extend quality healthcare facilities to people across boundaries. There is a lot of opportunities for healthcare ventures in the African continent.”
DM Healthcare has started MIMS, a 600-bed tertiary care hospital in Calicut and a 150-bed hospital at Kottakkal, Kerala. In addition, Aster Medcity, a green field venture involving $300 million investment in two phases is coming up in Kochi, Kerala. The group has also expanded to other parts of India through acquisitions. DM Healthcare is currently present in the UAE, Saudi Arabia, Oman and Qatar and in India and operates about 40 medical centres, 7 hospitals, 79 pharmacies and nearly 3,000 medical professionals. The UAE-based Julphar Pharmaceuticals, Neo Paharma, Elis Pharmaceuticals etc are some of the successful pharmaceutical manufacturers in the UAE. Source: Emirates 24/7 January/February 2016 | 44
www.middleeasthospital.com
MioCARE - Real-world tested benefits and features
RUGGED TABLET DESIGN MioCARE tablets are tested to withstand drops onto concrete. The award winning rugged designs offer protection while remaining ergonomic, portable, lightweight and easy to use. Our tablets resilience means they can stand up to the spills, bumps and scrapes they are constantly exposed to in healthcare environments.
BARCODE SCANNING Selected MioCARE tablets use barcode scanning technology from leading providers. With the option of 1D laser or 1D/2D imagers, and the front and rear cameras integrated in all MioCARE tablets, healthcare professionals can work with increased efficiency and accuracy. Zero dust ingression and are 1 metre submersible for up to 30 minutes – ideal for your field staff operating in the toughest environments.
INFECTION CONTROL
MioCARE products ensure nurses and doctors get more face time with their patients, improving the care they deliver.
MioCARE has been designed with optimal hygiene and infection control in mind and our tablets are fully clean-able with commonly used disinfectants to ensure reliability in the day-to-day healthcare business. All devices have been manufactured with antimicrobial casings for further protection. Our optional single or multiunit power data cradles are also cleanable, always charged and ready to use.
A leader in the global ICT Industry, MiTAC International Corp. was founded in 1982, and designs as well as manufactures award-winning technology product for the automotive, enterprise, medical and fitness markets. With a global workforce of 9,000, the company achieved revenues of US$1.5B in 2012. www.mitac.com MioCARE™ is MiTAC’s range of rugged handheld tablets dedicated to Healthcare. The brand is represented in Europe by MiTAC Europe, a wholly-owned subsidiary of MiTAC International Corp. miocare.mio.com
MioCARE has been designed by leveraging MiTAC International Corp’s full range of electronics manufacturing services from research and develop ment to enterprise service centres. Our series of tablets provide real-world solutions to everyday challenges and are made specifically with the ever changing healthcare environment in mind. The introduction of our tablets brings flexibility previously unattainable through desktop or paper administration. With MioCARE, monitoring and recording patient information and care plans, including medication plans, can now be conducted at the bedside, increasing face-time with the patient, while reducing or even removing room for errors. We work with healthcare professionals (HCP’s) and world renowned medical centres as well as software companies to provide tailored technology solutions that give HCP’s the information they need when and where they need it.
Award winning designed products built specifically for healthcare professionals
Middle East Hospital magazine
ARAB HEALTH 2016 - MALEM MEDICAL For 30 years regular exhibitors Malem Medical have been manufacturing the world’s best and largest range of Enuresis Alarms and Vibrating Watches (left) for the treatment and permanent cure of Nocturnal as well as Diurnal Enuresis. With the latest Universal Wireless alarm you can use up to seven transmitters, each one of them can be attached to a different sensor (such as Enuresis body worn Sensor; Bed-Mat Enuresis Sensor; Pressure-Mat; and Pressure Release Mat) to help detect patient movement and prevent dangerous falling or unauthorised wandering. Regular exhibitors Adam,Rouilly showcased their impressive range of medical training aids, including the Desperate Deborah, a revolutionary new simulator for training of impaction of a fetal head at caesarian section, alongside popular existing products such as the venepuncture and infusion arm (below), and Hungry Manikin.
www.middleeasthospital.com
lth and Inn Hea o 10
MEH
n tio va
20
April2011_Jan2011 24/03/2011 21:44 Page 21
Official Nominee for 2010 Awards
For For 24 years years Dr. Dr. Abdulrahman Al Mishar Misharii Hospital has been providing providing high quality of Medical Car Caree to its patients. MISSION STATEMENT Dr. Abdul Rahman Al-Mishari Hospital is committed to Superior Quality and Safety in meeting the Health care needs of the clients we serve by Fostering Advanced and Compassionate Health care Services. VISION STATEMENT We shall treat each patient like a member of our own family thus providing Superior Quality Health care Services and to be recognized as the center of excellence in the Management of Obstetrics, Gynecology and Pediatrics in the Central Region of Kingdom of Saudi Arabia.
www.drabdulrahmanalmishari.com.sa
Events
Middle East Hospital magazine
January 2016
December 2015
Qatar International Medical Devices & Healthcare Exhibition & Conference 2 – 4 Dec, 2015 Doha, Qatar www.qmedexpo.com
International Conference on Genetics, Biological & Life Sciences (GBLS-16) Dubai-UAE 10 – 11 Jan, 2016 Dubai, UAE cbmsr.org/conference.php
MEDEXCON 2015 2 – 4 Dec, 2015 Ankara, Turkey www.medexcon.net/Eng Eyaf Expo 2015 3 – 6 Dec, 2015 Istanbul, Turkey www.engelsizyasamfuari.com The International Congress in Aesthetics, Anti-Ageing Medicine & Medical Spa (ICAAM) 4 – 5 Dec, 2015 Dubai, UAE www.antiageingme.com IOF Regional’s 3rd Middle East and Africa Osteoporosis Meeting 5 – 7 Dec, 2015 Abu Dhabi, UAE www.iofbonehealth.org /abudhabi-2015 The First Saudi International Lab Expo 2015 6 – 8 Dec, 2015 Riyadh, KSA www.saudilabexpo.com
MEAAAIC 2015 Middle East-Asia Allergy Asthma, Immunology Congress 2015 10 – 12 Dec, 2015 Abu Dhabi, UAE meaaaic.org
Dubai, UAE
eso-congress.org
IMTEC Oman 2016 18 – 20 Jan, 2016 Muscat, Oman www.imtecoman.com 6th Emirates Otorhinolarygology, Audiology & Communication Disorder Congress 13 – 15 Jan, 2016 Dubai, UAE www.emirates rhinologyandotology.ae ISER- 2nd International Conference on Science, Health and Medicine (ICSHM) 16 Jan 2016 Dubai, UAE iser.co 1st Middle-Eastern Conference for Stereotactic and Functional Neurosurgery 16 – 18 Jan, 2016 Dubai, UAE www.msfns.org
ESEM Scientific Conference 6 – 10 Dec, 2015 Dubai, UAE www.saudilabexpo.com
16th Emirates Society of Ophthalmology Congress
The Breast and Gynecological 14 – 15 Jan, International Cancer Conference 2016 Cairo, Egypt www.bgicc.eg.net
10 – 12 Dec, 2015
Radiology Symposium 11 Dec, 2015 Abu Dhabi, UAE cme@alnoorhospital.com
Gulf Arrhythmia Congress 21 – 23 Jan, 2016 Dubai, UAE www.gulfarrhythmia.org The ICID 2016: 18th International Conference on Infectious Disease 26 – 27 Jan, 2016 Jeddah, KSA www.waset.org Arab Health 2016 28 – 31 January, 2016 Dubai, UAE www.arabhealthonline.com
ICACCM 2015: 17th Int’l Conference on Anaesthesiology and Critical Care Medicine 23 – 24 Dec, 2015 Dubai, UAE www.waset.org ICBMJD 2015: 17th Int’l Conference on Bone, Muscle and Joint Diseases 23 – 24 Dec, 2015 Dubai, UAE www.waset.org on Virology and Infectious Diseases 23 – 24 Dec, 2015 Dubai, UAE www.waset.org International Conference on Genetics, Biological & Life Sciences (GBLS-16) DubaiUAE 10 – 11 Jan, 2016
www.middleeasthospital.com
10 – 11 Jan, 2016
Jan2016 | 50
Middle East Hospital Ad - Dec 2012_PRINT.pdf
1
21/12/2012
10:43
ContactÊourÊsalesÊteamÊforÊdetails: T:Ê+44Ê1422Ê233Ê000Ê/ÊE:Êsales@sidhil.com DevelopedÊandÊmanufacturedÊinÊtheÊUK,ÊSidhilÕsÊInnov8ÊrangeÊincludesÊaÊbedÊforÊevery specification,ÊfromÊhighÊdependencyÊenvironmentsÊthroughÊtoÊutilityÊwardÊbeds.
...making it better
C
M
Y
CM
DesignedÊforÊeaseÊofÊuse andÊworldÊclassÊinfection control,ÊInnov8ÊbedsÊare reliableÊandÊeasyÊto maintain,Êincorporating superbÊergonomicsÊin termsÊofÊbothÊmanual handlingÊandÊuser comfort.
MY
CY
CMY
K
Innov8Ê4000 AdvancedÊwardÊbedÊwithÊsplitÊsideÊrails
Innov8Ê2000Ê ElectricallyÊoperatedÊprofiling wardÊbed
Innov8Ê6000 BedÊforÊhighÊdependancy units
Innov8ÊLow ExceptionalÊlow-to-high rangeÊ22ÊtoÊ70cm
COMEÊANDÊSEEÊUSÊATÊARABÊHEALTH:ÊÊÊ25-28 January 2016 DubaiÊInternationalÊConventionÊ&ÊExhibitionÊCentreÊ-ÊSTANDÊZ1 G51 MEHJan2013.indd 52
19/01/2013 10:56:56